Elisa Bonomi
Milan, 20132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Double activation and low IL-2 manufacturing protocol increase expansion of healthy and patient-derived CAR-Tregs.
Journal: Molecular therapy. Advances
Published: August 14, 2025
Cerebrospinal fluid from frontotemporal dementia patients is toxic to neurons.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 21, 2021
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 17, 2020
Cyclase-associated protein 2 dimerization regulates cofilin in synaptic plasticity and Alzheimer's disease.
Journal: Brain communications
Published: January 24, 2020
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?
Journal: Journal of neuroimmunology
Published: June 07, 2018
Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.
Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.
Journal: Scientific reports
Published: January 07, 2018
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: October 10, 2017
Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation.
Journal: Journal of Alzheimer's disease : JAD
Published: March 18, 2017
Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.
Journal: Journal of Alzheimer's disease : JAD
Published: January 28, 2017
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.
Journal: Scientific reports
Published: January 25, 2017
Last Updated: 09/26/2026